NOX4 and cancer: Assessing DNA methylation alterations, crucial for the identification of diagnostic and prognostic biomarkers, revealed NOX4 hypermethylation in various cancer types, including BRCA, LUSC, BLCA, LUAD, PRAD, UCEC, STAD, THCA, and CHOL (Figure 3A).